Patient Opportunity

Agam is a 12-year-old girl who, until about a year and a half of age, was developing typically and living a peaceful, stable early childhood. Gradually, subtle but concerning changes began to emerge. She became increasingly selective with food, favoring simple carbohydrates and sweets. Over time, she began mouthing non-food items, such as toilet paper. Her eye contact diminished, her ability to communicate declined, and she eventually stopped speaking altogether.

Once a cheerful, expressive child, Agam slowly withdrew into a world of silence. A formal diagnosis soon followed as Agam was identified as being on the autism spectrum. This diagnosis marked a profound turning point in her life and opened the door to exploring deeper clinical insights and potential therapeutic opportunities aimed at supporting her development, communication, and overall well-being.

Approach

As both a pharmacist and chemist, I knew the most effective way to understand what was happening inside Agam’s body was through comprehensive laboratory evaluation. Suspecting nutritional imbalances and metabolic disruption, I ordered an in-depth testing panel, including MosaicDX’s Organic Acids Test (OAT).

Key Findings

The results offered clarity and a roadmap for intervention:

  • Low serotonin indicators.
  • Fungal overgrowth.
  • Elevated FDCA and HMFA.
  • Oxidative stress + mitochondrial dysfunction.

These insights guided a targeted, three-step clinical strategy:

  1. Restore Gut Balance by addressing fungal overgrowth and support microbiome resilience.
  2. Correct Nutrient Deficiencies by replenishing essential vitamins and minerals foundational for metabolic and neurological health.
  3. Reduce Oxidative Stress by strengthening mitochondrial activity and improve cellular energy metabolism.

Results

With consistent intervention and ongoing monitoring, significant improvements were observed:


*The patient name has been changed to protect their privacy.

This material is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Use of this information is at the reader’s discretion and risk.


Insights That Lead to Impact 

Now, are you ready to share your success? Let your story inspire others and showcase the incredible impact of your expertise.  

Experienced practitioners, submit your case study and inspire others.

About the Author

Dr. Tali Engor

Tali Engor developed the C.A.T. Method after her daughter was diagnosed with autism spectrum disorder.

Today, she runs the C.A.T. Center, works closely with families, and oversees a team of experts. Tali, an expert in pharmaceutical chemistry, chemist, and licensed pharmacist, holds a B.Sc.Pharm from the Hebrew University of Jerusalem and a B.Sc. in Pharmaceutical Chemistry from Bar-Ilan University. In addition, Tali has specializations and certifications from the Levinsky College (The Autism Integrative Method Program), Ben-Gurion University (Naturopathic Studies), the Hebrew University of Jerusalem (Psychiatry and Neurology, and Diabetes and Medicinal Consultation), and was a former council member of the Pharmaceutical Society of Israel.

Leveraging her background in science and medicine, Tali developed a custom autism treatment program based on biologically-based practices in order to reduce autism symptoms by repairing impaired metabolic processes and restoring the patient’s internal biochemical balance.